[Single-ventricle heart defects--long-term prognosis, late complications and quality of life]

Taisto Sarkola1, Jaana Pihkala, Heta Nieminen

  • 1Division of Cardiology, Labatt Family Heart Center, Hospital for Sick Children, 555 University Ave, Toronto, Ontario, M5G 1X8 Canada.

Duodecim; Laaketieteellinen Aikakauskirja
|April 4, 2009
PubMed

Insights

Single-ventricle heart defects require blood flow redirection. Many adults face long-term issues like heart failure and arrhythmias, impacting quality of life.

Area of Science:

  • Cardiology
  • Pediatric Cardiac Surgery
  • Congenital Heart Disease

Context:

  • Single-ventricle physiology presents unique challenges in managing systemic and pulmonary blood flow.
  • Surgical palliation aims to reroute venous return directly to the pulmonary artery, bypassing the underdeveloped right ventricle.
  • Increasing survival rates mean more adults live with complex single-ventricle physiology.

Purpose:

  • To describe the long-term outcomes and complications associated with the surgical palliation of single-ventricle heart defects.
  • To highlight the prevalence and nature of late sequelae in adult survivors.
  • To underscore the ongoing need for specialized adult congenital cardiology care.

Summary:

  • Treatment involves redirecting systemic venous blood to the pulmonary artery without right heart involvement.
  • A significant proportion of adults with single-ventricle defects experience late complications.
  • Common issues include heart failure, arrhythmias, cyanosis, thromboembolic events, and neurological deficits.

Impact:

  • Improved understanding of long-term morbidity in single-ventricle survivors.
  • Highlights the critical need for lifelong monitoring and management of these complex patients.
  • Informs strategies for enhancing quality of life and addressing specific complications in adult congenital heart disease.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...